Synonyms Blood and Lymphatic Disorders, Blood and Lymphatic System Disorders, Blood and lymphatic system disorders + [12] |
Introduction Hematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., ERYTHROCYTE AGGREGATION, INTRAVASCULAR) and chemical components (e.g., BLOOD PROTEIN DISORDERS); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes. |
Target |
Mechanism F9 gene stimulants [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date08 Apr 2025 |
Target |
Mechanism AT III inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date28 Mar 2025 |
Target |
Mechanism CSF-3R agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. European Union [+3] |
First Approval Date28 Mar 2025 |
Start Date02 Oct 2640 |
Sponsor / Collaborator- |
Start Date14 Nov 2031 |
Sponsor / Collaborator- |
Start Date01 Jan 2028 |
Sponsor / Collaborator |